[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 192,816
  • Shares Outstanding, K 59,328
  • Annual Sales, $ 1,080 M
  • Annual Income, $ 95,400 K
  • EBIT $ 269 M
  • EBITDA $ 329 M
  • 60-Month Beta 0.83
  • Price/Sales 0.18
  • Price/Cash Flow 0.84
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 137.26% (+27.14%)
  • Historical Volatility 54.52%
  • IV Percentile 92%
  • IV Rank 58.97%
  • IV High 202.64% on 05/15/26
  • IV Low 43.29% on 08/29/25
  • Expected Move (DTE 31) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.65
  • Today's Volume 130
  • Volume Avg (30-Day) 110
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 6,286
  • Open Int (30-Day) 6,168
  • Expected Range 3.44 to 3.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.26
  • Number of Estimates 1
  • High Estimate $0.26
  • Low Estimate $0.26
  • Prior Year $1.12
  • Growth Rate Est. (year over year) -76.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.01 +14.29%
on 06/23/26
3.50 -1.71%
on 06/29/26
+0.33 (+10.61%)
since 06/18/26
3-Month
2.77 +24.19%
on 05/20/26
9.65 -64.35%
on 04/21/26
-6.16 (-64.17%)
since 04/20/26
52-Week
2.77 +24.19%
on 05/20/26
15.55 -77.88%
on 09/17/25
-6.34 (-64.83%)
since 07/18/25

Most Recent Stories

More News
Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , July 16, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz  announces that investors with losses related to Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC ) have...

EMBC : 3.44 (+5.85%)
Robbins LLP Reminds EMBC Stockholders of the Securities Fraud Class Action; Contact the Firm for Information About Your Rights 

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and...

EMBC : 3.44 (+5.85%)
EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff Deadline in Embecta Corp. Securities Class Action - Contact SueWallSt

Wall Street Turned Bearish on Embecta After a "Major Miss" Exposed the Gap Between Management's "Incredibly Resolute" Pen Needle Claims and a 57.8% Single-Day Stock Collapse

EMBC : 3.44 (+5.85%)
EMBC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Embecta Corp. Securities Lawsuit - Contact Levi & Korsinsky

Embecta Promised Investors Flat-to-Down-2% Revenue and $2.80–$3.00 EPS — Then Delivered a 17.4% Revenue Collapse and Slashed Earnings Guidance by Nearly Half

EMBC : 3.44 (+5.85%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC

NEW YORK , July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised...

EMBC : 3.44 (+5.85%)
EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit-- HBSS

SAN FRANCISCO , July 16, 2026 /PRNewswire/ -- Embecta Corp. ( NASDAQ: EMBC ) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common...

EMBC : 3.44 (+5.85%)
EMBC Fraud Notice: Embecta Investors are Reminded to Contact BFA Law about the Filed Securities Fraud Class Action Lawsuit to Recover Investment Losses

A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin...

EMBC : 3.44 (+5.85%)
Lost Money on Embecta Corp. (EMBC)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Important Notice Regarding Alleged Pen Needle Revenue Misrepresentations That Cost Embecta Investors Over 57% of Share Value

EMBC : 3.44 (+5.85%)
EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit-- HBSS

SAN FRANCISCO , July 14, 2026 /PRNewswire/ -- Embecta Corp. ( NASDAQ: EMBC ) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common...

EMBC : 3.44 (+5.85%)
Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , July 14, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

EMBC : 3.44 (+5.85%)

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 3.68
2nd Resistance Point 3.56
1st Resistance Point 3.50
Last Price 3.44
1st Support Level 3.33
2nd Support Level 3.21
3rd Support Level 3.15

See More

52-Week High 15.55
Fibonacci 61.8% 10.67
Fibonacci 50% 9.16
Fibonacci 38.2% 7.65
Last Price 3.44
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.